TB-500 and BPC-157 Blend

No Retratrutide

Multi-Agonist Peptide for Weight Loss & Metabolic Health

Formulation: Retratrutide (5mg) – Research Use Only

Description:

Retratrutide is a next-generation investigational peptide that combines the power of three hormone pathways into one compound. It acts as a triple agonist, targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—a combination designed to deliver potent effects on appetite suppression, metabolic function, and fat loss.

Potential Benefits:

Significant reduction in body weight and fat mass

Enhanced glucose control and insulin sensitivity

Improved energy expenditure

Appetite regulation and reduced cravings

Cardiometabolic health support

Mechanism of Action:

By activating GLP-1, GIP, and glucagon receptors simultaneously, Retratrutide may offer superior metabolic effects compared to single or dual agonist therapies. This multi-receptor synergy is designed to mimic the body’s natural hormonal response to food intake and energy regulation

Ozempic (Semaglutide)

Ozempic (Semaglutide) is a once-weekly injectable GLP-1 receptor agonist originally designed for managing type 2 diabetes. It has gained widespread use for weight loss and appetite suppression, making it a powerful tool for fat reduction and metabolic optimization.